Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015, Article ID 405157, 6 pages
http://dx.doi.org/10.1155/2015/405157
Research Article

Effect of Orexin-A on Cortisol Secretion in H295R Cells via p70S6K/4EBP1 Signaling Pathway

1Department of Endocrinology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China
2Department of Orthopedic Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China

Received 2 September 2014; Revised 2 March 2015; Accepted 24 April 2015

Academic Editor: Muhammad Shahab

Copyright © 2015 Xiaocen Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. de Lecea, T. S. Kilduff, C. Peyron et al., “The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 322–327, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Sakurai, A. Amemiya, M. Ishii et al., “Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior,” Cell, vol. 92, no. 4, pp. 573–585, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ammoun, T. Holmqvist, R. Shariatmadari et al., “Distinct recognition of OX1 and OX2 receptors by orexin peptides,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 2, pp. 507–514, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Voisin, P. Rouet-Benzineb, N. Reuter, and M. Laburthe, “Orexins and their receptors: structural aspects and role in peripheral tissues,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 72–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. T.-R. Xu, Y. Yang, R. Ward, L. Gao, and Y. Liu, “Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders,” Cellular Signalling, vol. 25, no. 12, pp. 2413–2423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. K. Malendowicz, N. Jedrzejczak, A. S. Belloni, M. Trejter, A. Hochól, and G. G. Nussdorfer, “Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands,” Histology and Histopathology, vol. 16, no. 3, pp. 713–717, 2001. View at Google Scholar · View at Scopus
  7. G. Mazzocchi, L. K. Malendowicz, L. Gottardo, F. Aragona, and G. G. Nussdorfer, “Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 778–782, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Spinazzi, M. Rucinski, G. Neri, L. K. Malendowicz, and G. G. Nussdorfer, “Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3544–3549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Ziolkowska, R. Spinazzi, G. Albertin et al., “Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor,” Journal of Steroid Biochemistry and Molecular Biology, vol. 96, no. 5, pp. 423–429, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ramanjaneya, A. C. Conner, J. Chen, P. R. Stanfield, and H. S. Randeva, “Orexins stimulate steroidogenic acute regulatory protein expression through multiple signaling pathways in human adrenal H295R cells,” Endocrinology, vol. 149, no. 8, pp. 4106–4115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wenzel, N. Grabinski, C. A. Knopp et al., “Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 297, no. 5, pp. R1601–R1609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Samuels and V. E. Velculescu, “Oncogenic mutations of PIK3CA in human cancers,” Cell Cycle, vol. 3, no. 10, pp. 1221–1224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Grozinsky-Glasberg, G. Franchi, M. Teng et al., “Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell line,” Neuroendocrinology, vol. 87, no. 3, pp. 168–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Grozinsky-Glasberg, H. Rubinfeld, Y. Nordenberg et al., “The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells,” Molecular and Cellular Endocrinology, vol. 315, no. 1-2, pp. 87–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Harthill, M. P. Rubio, F. C. Milne, and C. MacKintosh, “Regulation of the 14-3-3-binding protein p39 by growth factors and nutrients in rat PC12 pheochromocytoma cells,” Biochemical Journal, vol. 368, no. 2, pp. 565–572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Guertin and D. M. Sabatini, “Defining the role of mTOR in cancer,” Cancer Cell, vol. 12, no. 1, pp. 9–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Ruggero, L. Montanaro, L. Ma et al., “The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis,” Nature Medicine, vol. 10, no. 5, pp. 484–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Furic, L. Rong, O. Larsson et al., “EIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14134–14139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Sonenberg, “eIF4E, the mRNA cap-binding protein: from basic discovery to translational research,” Biochemistry and Cell Biology, vol. 86, no. 2, pp. 178–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Nardella, A. Lunardi, G. Fedele et al., “Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis,” Cancer Research, vol. 71, no. 10, pp. 3669–3675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. C. de Martino, R. A. Feelders, W. W. de Herder et al., “Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors,” Endocrine-Related Cancer, vol. 21, pp. 601–613, 2014. View at Google Scholar
  22. M. Doghman and E. Lalli, “Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma,” Molecular and Cellular Endocrinology, vol. 364, no. 1-2, pp. 101–104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ramanjaneya, A. C. Conner, J. Chen et al., “Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B,” Journal of Endocrinology, vol. 202, no. 2, pp. 249–261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Sokołowska, A. Urbańska, K. Biegańska et al., “Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling,” Journal of Molecular Neuroscience, vol. 52, no. 1, pp. 48–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Chen, Y. Zhao, D. Zheng, S. Ju, Y. Shen, and L. Guo, “Orexin A affects INS-1 rat insulinoma cell proliferation via orexin receptor 1 and the AKT signaling pathway,” International Journal of Endocrinology, vol. 2013, Article ID 854623, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Johansson, M. E. Ekholm, and J. P. Kukkonen, “Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx,” British Journal of Pharmacology, vol. 150, no. 1, pp. 97–104, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Holmqvist, L. Johansson, M. Östman, S. Ammoun, K. E. O. Åkerman, and J. P. Kukkonen, “OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms,” The Journal of Biological Chemistry, vol. 280, no. 8, pp. 6570–6579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Magga, G. Bart, C. Oker-Blom, J. P. Kukkonen, K. E. O. Åkerman, and J. Näsman, “Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1,” Biochemical Pharmacology, vol. 71, no. 6, pp. 827–836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Tang, J. Chen, M. Ramanjaneya, A. Punn, A. C. Conner, and H. S. Randeva, “The signalling profile of recombinant human orexin-2 receptor,” Cellular Signalling, vol. 20, no. 9, pp. 1651–1661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Urbańska, P. Sokołowska, A. Woldan-Tambor et al., “Orexins/hypocretins acting at Gi protein-coupled OX2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures,” Journal of Molecular Neuroscience, vol. 46, no. 2, pp. 10–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Woldan-Tambor, K. Biegańska, A. Wiktorowska-Owczarek, and J. B. Zawilska, “Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes,” Pharmacological Reports, vol. 63, no. 3, pp. 717–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhu, Y. Miwa, A. Yamanaka et al., “Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and -insensitive G-proteins,” Journal of Pharmacological Sciences, vol. 92, no. 3, pp. 259–266, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Su, Y. Gu, F. Li et al., “The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism,” PLoS ONE, vol. 8, no. 4, Article ID e62399, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. V. Heinonen, A. K. Purhonen, K. A. Mäkelä, and K. H. Herzig, “Functions of orexins in peripheral tissues,” Acta Physiologica, vol. 192, no. 4, pp. 471–485, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Arihara, K. Takahashi, O. Murakami et al., “Immunoreactive orexin-A in human plasma,” Peptides, vol. 22, no. 1, pp. 139–142, 2001. View at Publisher · View at Google Scholar · View at Scopus